ACS recommends biennial prostate screening for most men

The American Cancer Society now recommends prostate-specific antigen (PSA) screening every two years for men at average risk ages 50 to 69, and annually starting at 45 for Black men and men with a strong family history. Men ages 70 to 74 should discuss screening with a health care provider, weighing their health and life expectancy. The change reflects evidence that regular screening can reduce deaths from prostate cancer, while addressing concerns that PSA tests can lead to unnecessary treatment and serious side effects. The society hopes clearer guidance will increase screening and help prevent advanced disease.